The Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) and MitoPower LLC ("MitoPower") were
Read more
Home »
The ethics of split liver transplantation: Analyzing case studies to make the right decision
Split liver transplantation (SLT) provides an opportunity to divide a donor liver and offer transplants to two small patients, one
Read more
The FDA expands collaboration with CN Bio to investigate lung-on-a-chip model for inhaled drug evaluation applications
CN Bio, a leading developer of single- and multi-organ-on-chip microphysiological systems (MPS) that improve the accuracy and efficiency of drug
Read more
Quantitative detection of fatty liver disease by assessing fat distribution in the liver
Nonalcoholic fatty liver disease (NAFLD) is a pathological condition characterized by excessive fat stored in the liver that is not
Read more
Fatty liver hepatitis is caused by auto-aggressive immune cells
Non-alcoholic steatohepatitis (NASH), often called ‘fatty liver hepatitis,’ can lead to serious liver damage and liver cancer. A team of
Read more
CN Bio awarded Innovate UK grant to develop single and multi-organ models for COVID-19 research
CN Bio, a leading developer of single and multi-organ microphysiological systems (MPS), otherwise known as organ-on-a-chip, today announced it has
Read more
Novel finding could lead to better treatments for Type 1 and Type 2 diabetes
Monash University researchers have uncovered the barrier to β-cell (beta cell) regeneration that could pave the way for improved treatments
Read more
When liver cirrhosis is deadly
When the body can no longer compensate the gradual failure of the liver caused by liver cirrhosis, there is a
Read more
New treatment extends lives of people with most common type of liver cancer
For the first time in over a decade, scientists have identified a first-line treatment that significantly improves survival for people
Read more
Hospitalizations for chronic liver disease on the rise
(HealthDay)—Hospitalizations for chronic liver disease (CLD) increased from 2012 to 2016, reaching a total estimated national cost of $81.1 billion,
Read more